rad5
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00801697)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rad5
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01479296 | Phase 1 | Dec 1, 2011 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pennsylvania |
| NCT01095224 | Phase 1 | Sep 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00961883 | Phase 1 | Aug 1, 2009 | EuroVacc Foundation, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT00801697 | Phase 1 | Feb 1, 2009 | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, University of Lausanne |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 4 | 3 | 1 | 2009 |
| HIV Vaccine Trials Network | Academic/Hospital | 2 | 1 | 1 | 2009 |
| University of Lausanne | Academic/Hospital | 2 | 0 | 1 | 2009 |
| EuroVacc Foundation | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2010 |
7 organizations
Page 1 / 1